(210) | Number of the EPO application | 18708025 |
(220) | Filing date of the EPO application | 2018.02.15 |
(80) | EPO patent specification publication (B) | EPB nr. 40/2022, 2022.10.05 |
(110) | EPO patent number | 3583120 |
(11) | Number of the document | MD 3583120 T2 |
(21) | Number of the application | e 2020 0008 |
(71) | Name(s) of applicant(s), code of the country | Denali Therapeutics Inc., US; |
(72) | Name(s) of inventor(s), code of the country | CHEN Xiaocheng, US; DENNIS Mark S., US; KARIOLIS Mihalis, US; SILVERMAN Adam P., US; SRIVASTAVA Ankita, US; WATTS Ryan J., US; WELLS Robert C., US; ZUCHERO Joy Yu, US; |
(73) | Name(s) of owner(s), code of the country | Denali Therapeutics Inc., US; |
(54) | Title of the invention | Engineered transferrin receptor binding polypeptides |
(13) | Kind-of-document code | T2 |
(51) | International Patent Classification | C07K 14/79 (2006.01.01); C07K 14/705 (2006.01.01); A61K 38/00 (2006.01.01); A61K 39/00 (2006.01.01) |
(19) | Country | US |
(41) | Date of publication of the application | 2020.02.29 |
(49) | Date of publication of the translation of the validated European patent specification | 2023.02.28 |
(30) | Priority | 201762460692 P, 2017.02.17, US; 201762543658 P, 2017.08.10, US; 201762583314 P, 2017.11.08, US |
(74) | Patent attorney | (Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova |
(86) | International application | PCT/US2018/018371, 2018.02.15 |
(87) | International publication | WO 2018/152326, 2018.08.23 |